BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Roth JD, Feigh M, Veidal SS, Fensholdt LK, Rigbolt KT, Hansen HH, Chen LC, Petitjean M, Friley W, Vrang N, Jelsing J, Young M. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. World J Gastroenterol 2018; 24(2): 195-210 [PMID: 29375205 DOI: 10.3748/wjg.v24.i2.195]
URL: https://www.wjgnet.com/1007-9327/full/v24/i2/195.htm
Number Citing Articles
1
Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne S. Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 369 doi: 10.1007/978-3-030-11748-1_14
2
Ruicong Sun, Chunjin Xu, Baisui Feng, Xiang Gao, Zhanju Liu. Critical roles of bile acids in regulating intestinal mucosal immune responsesTherapeutic Advances in Gastroenterology 2021; 14: 175628482110180 doi: 10.1177/17562848211018098
3
Beatrice Anfuso, Claudio Tiribelli, Luciano Adorini, Natalia Rosso. Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro modelScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58562-x
4
Marlena M. Holter, Margot K. Chirikjian, Viraj N. Govani, Bethany P. Cummings. TGR5 Signaling in Hepatic Metabolic HealthNutrients 2020; 12(9): 2598 doi: 10.3390/nu12092598
5
Richard Radun, Michael Trauner. Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic OpportunitiesSeminars in Liver Disease 2021; 41(04): 461 doi: 10.1055/s-0041-1731707
6
Jonathan D. Roth, Sanne S. Veidal, Louise K. D. Fensholdt, Kristoffer T. G. Rigbolt, Romeo Papazyan, Jens Christian Nielsen, Michael Feigh, Niels Vrang, Mark Young, Jacob Jelsing, Luciano Adorini, Henrik H. Hansen. Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASHScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45178-z
7
Josué Orozco-Aguilar, Felipe Simon, Claudio Cabello-Verrugio, Anwen Shao. Redox-Dependent Effects in the Physiopathological Role of Bile AcidsOxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/4847941
8
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, Marc Foretz, Patrick C. Even, Dalila Azzout‐Marniche, Andreas Nygaard Madsen, Martin Illemann, Karen Mandrup, Michael Feigh, Jörg Czech, Heiner Glombik, Jacob A. Olsen, Wolfgang Hennerici, Klaus Steinmeyer, Ralf Elvert, Tamara R. Castañeda, Aimo Kannt. Activation of Adenosine Monophosphate—Activated Protein Kinase Reduces the Onset of Diet‐Induced Hepatocellular Carcinoma in MiceHepatology Communications 2020; 4(7): 1056 doi: 10.1002/hep4.1508
9
Hong Wang, Qingxian He, Guangji Wang, Xiaowei Xu, Haiping Hao. FXR modulators for enterohepatic and metabolic diseasesExpert Opinion on Therapeutic Patents 2018; 28(11): 765 doi: 10.1080/13543776.2018.1527906
10
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat sourceWorld Journal of Gastroenterology 2019; 25(33): 4904-4920 doi: 10.3748/wjg.v25.i33.4904
11
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, Michael Feigh, Niels Vrang, Jonathan David Roth, Mary Erickson, Luciano Adorini, Jacob Jelsing. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASHBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1149-z
12
Verena Keitel, Jan Stindt, Dieter Häussinger. Bile Acids and Their ReceptorsHandbook of Experimental Pharmacology 2019; 256: 19 doi: 10.1007/164_2019_230
13
Meng-jun Chen, Chen Liu, Yue Wan, Lei Yang, Shu Jiang, Da-wei Qian, Jin-ao Duan. Enterohepatic circulation of bile acids and their emerging roles on glucolipid metabolismSteroids 2021; 165: 108757 doi: 10.1016/j.steroids.2020.108757
14
Alessia Perino, Hadrien Demagny, Laura Velazquez-Villegas, Kristina Schoonjans. Molecular physiology of bile acid signaling in health, disease, and agingPhysiological Reviews 2021; 101(2): 683 doi: 10.1152/physrev.00049.2019
15
Jin Chen, Minghua Zheng, Jun Liu, Yan Luo, Wenjun Yang, Jing Yang, Juan Liu, Jingxing Zhou, Chengfu Xu, Faling Zhao, Mingming Su, Shufei Zang, Junping Shi. Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic SteatohepatitisObesity 2019; 27(12): 2055 doi: 10.1002/oby.22627
16
Caihua Wang, Chunpeng Zhu, Liming Shao, Jun Ye, Yimin Shen, Yuezhong Ren. Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver DiseaseMediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/7659509
17
Martine C. Morrison, Lars Verschuren, Kanita Salic, Joanne Verheij, Aswin Menke, Peter Y. Wielinga, Marta Iruarrizaga‐Lejarreta, Laurent Gole, Wei‐Miao Yu, Scott Turner, Martien P.M. Caspers, Ibon Martínez‐Arranz, Elsbet Pieterman, Reinout Stoop, Arianne van Koppen, Anita M. van den Hoek, José M. Mato, Roeland Hanemaaijer, Cristina Alonso, Robert Kleemann. Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden MiceHepatology Communications 2018; 2(12): 1513 doi: 10.1002/hep4.1270
18
Jiezhong Chen, Michael Thomsen, Luis Vitetta. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probioticsJournal of Cellular Biochemistry 2019; 120(3): 2713 doi: 10.1002/jcb.27635
19
Chao Li, Jie Yang, Yu Wang, Yingzi Qi, Wenqing Yang, Yunlun Li. Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic DiseasesFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01247
20
L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating PeptidesFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.597583
21
Benoit Smeuninx, Ebru Boslem, Mark A. Febbraio. Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver DiseaseCancers 2020; 12(7): 1714 doi: 10.3390/cancers12071714
22
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2019; 64(5): 1238 doi: 10.1007/s10620-018-5395-7
23
Peng Zhao, Sheng-Na Han, Suyavaran Arumugam, Muhammad Nadeem Yousaf, Yanqin Qin, Joy X. Jiang, Natalie Julia Torok, Yonglin Chen, Mohd Salah Mankash, Junbao Liu, Jiansheng Li, Yasuko Iwakiri, Xinshou Ouyang. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 317(4): G387 doi: 10.1152/ajpgi.00054.2019
24
Simona De Marino, Carmen Festa, Valentina Sepe, Angela Zampella. Bile Acids and Their ReceptorsHandbook of Experimental Pharmacology 2019; 256: 137 doi: 10.1007/164_2019_237
25
Shinobu Miyazaki-Anzai, Masashi Masuda, Shohei Kohno, Moshe Levi, Yuji Shiozaki, Audrey L. Keenan, Makoto Miyazaki. Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formationJournal of Lipid Research 2018; 59(9): 1709 doi: 10.1194/jlr.M087239
26
Sachiho Miyata, Yuji Kawashima, Miku Sakai, Masaya Matsubayashi, Keisuke Motoki, Yui Miyajima, Yousuke Watanabe, Noriko Chikamatsu, Tetsuya Taniguchi, Ryukou Tokuyama. Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonistsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88493-0
27
Margaux Nawrot, Simon Peschard, Sophie Lestavel, Bart Staels. Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver diseaseMetabolism 2021; 123: 154844 doi: 10.1016/j.metabol.2021.154844
28
Valérie Duvivier, Stéphanie Creusot, Olivier Broux, Aurélie Helbert, Ludovic Lesage, Kevin Moreau, Nicolas Lesueur, Lindsay Gerard, Karine Lemaitre, Nicolas Provost, Edwige-Ludiwyne Hubert, Tania Baltauss, Angelique Brzustowski, Nathalie De Preville, Julia Geronimi, Lucie Adoux, Franck Letourneur, Adel Hammoutene, Dominique Valla, Valérie Paradis, Philippe Delerive. Characterization and Pharmacological Validation of a Preclinical Model of Nash in Göttingen MinipigsJournal of Clinical and Experimental Hepatology 2021;  doi: 10.1016/j.jceh.2021.09.001
29
Rakesh Sahu, Rakhi Mishra, Chandana Majee. An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistanceExpert Review of Gastroenterology & Hepatology 2020; 14(10): 985 doi: 10.1080/17474124.2020.1797485
30
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing, Kristoffer T. G. Rigbolt. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01356-2
31
Chang Han. Update on FXR Biology: Promising Therapeutic Target?International Journal of Molecular Sciences 2018; 19(7): 2069 doi: 10.3390/ijms19072069